Neurocrine Biosciences
Clinical trials sponsored by Neurocrine Biosciences, explained in plain language.
-
New depression pill tested for quicker relief
Disease control CompletedThis study tested whether an investigational medicine called NBI-1070770 could help improve symptoms of major depression when added to a person's current antidepressant. 73 adults with depression took either the new medicine or a placebo pill for a short period. The main goal was…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 02, 2026 02:41 UTC
-
New drug tested to calm electrical storms in Children's brains
Disease control CompletedThis study tested whether an experimental drug called NBI-827104 could help children with a rare, severe form of epilepsy called epileptic encephalopathy with continuous spike-and-wave during sleep. Twenty-four children took the drug or a placebo daily for 13 weeks while research…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Hard-to-Treat schizophrenia symptoms
Disease control CompletedThis study tested whether adding a drug called valbenazine to a person's current antipsychotic medication could better control schizophrenia symptoms. It involved 442 adults whose symptoms weren't fully controlled by their existing medication. Participants were randomly assigned …
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for uncontrollable movements? drug study aims to ease debilitating side effect
Symptom relief CompletedThis study tested whether the drug valbenazine could improve daily life for people with tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to certain mental health medications. For 24 weeks, 59 adults with TD and conditions like schizophrenia or bi…
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC